STAT+: FDA delays enforcement of a pharmaceutical supply chain law to stop counterfeit drugs

The FDA has postponed its plans to enforce a law designed to thwart counterfeit or diverted medicines passing through the pharmaceutical supply chain.
Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks